A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories

Inclusion criteria:

• Participant must be ≥18 years of age, at the time of signing the informed consent.

• HIV negative at screening. Type of HIV-1 test is per standard of care.

• No prior history of receiving oral CAB or CAB LA injections.

• PrEP provider deems CAB PrEP use to be appropriate per the applicable CAB PrEPprescribing information prior to enrollment in the study.

• Female at birth or self-identified Transgender Female.

• Self-identified as African American/Black

• Capable of giving signed informed consent

Exclusion criteria:

• HIV indeterminate or positive test result during screening.

• A participant of concurrent interventional clinical or implementation science studyat any time during the study.

• Cis-gender or Transgender male